The Cascade Feasibility Pilot (HF) Phase 3
Primary Purpose
Heart Failure
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Non-invasive continuous remote monitoring with structured escalation pathway
Affective Analysis of Participant Response to Continuous Remote Patient Monitoring
Sponsored by
About this trial
This is an interventional health services research trial for Heart Failure
Eligibility Criteria
Inclusion Criteria:
- Patient is an inpatient at Evanston Hospital
- Patient is followed by the heart failure service team after discharge
- Patient has a history of heart failure
- Patient received at least one dose of IV diuretic at index hospitalization
- Symptoms corresponding to NYHA function class II-IV
- Patient has heart failure with reduced left ventricular ejection fraction (LVEF)<40%, or HF with mid-ranged ejection fraction (LVEF 40-50%), or HF with preserved ejection fraction (LVEF≥50%)
- Patient is in the top 50% risk of readmission across NorthShore University HealthSystem's CAPE 30-day readmission model
- Patient is at least 18 years of age
- Patient is fluent in English
- Patient agrees to protocol-required procedures
Exclusion Criteria:
- Patient has cognitive or physical limitations that, in the investigator's opinion, limit the patient's ability to maintain patch device and phone
- Patient has visual impairments
- Patient has an allergy to hydrocolloid adhesives
- Patient has present skin damage preventing them from wearing a study device
- Patient has renal dysfunction requiring dialysis
- Patient has CardioMEMS
- Pregnancy
- Patient receiving hospice care
Sites / Locations
- NorthShore University HealthSystem Evanston HospitalRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Pilot
Arm Description
45 eligible HF patients
Outcomes
Primary Outcome Measures
Attrition rate
Drop out from study
Enrollment rate
Enrollment rate for entire patient cohort
Adherence rate
Patient adherence to study protocol requirements
Time from discharge to first non-adherence event
Days from discharge to first non-adherence event, such as non-compliant use of wearable device
Secondary Outcome Measures
Documented Medication adherence counseling
Frequency of medication adherence counseling captured in a note within the electronic health record
Documented Dietary counseling
Frequency of dietary counseling captured in a note within the electronic health record
Documented Diuretic Escalation
Number of times clinical care team escalated patient standard diuretics dosage
30-day readmission rate
30-day readmission rate
Average number of clinical alerts from wearable platform
Average number of clinical events from wearable platform within 30 days
Full Information
NCT ID
NCT04993287
First Posted
July 16, 2021
Last Updated
January 11, 2022
Sponsor
NorthShore University HealthSystem
1. Study Identification
Unique Protocol Identification Number
NCT04993287
Brief Title
The Cascade Feasibility Pilot (HF) Phase 3
Official Title
The Cascade Feasibility Pilot (HF): Improving Care Processes for Heart Failure Patients Using Continuous Remote Patient Monitoring and a Cascading Alert System
Study Type
Interventional
2. Study Status
Record Verification Date
January 2022
Overall Recruitment Status
Recruiting
Study Start Date
June 17, 2021 (Actual)
Primary Completion Date
September 30, 2022 (Anticipated)
Study Completion Date
September 30, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
NorthShore University HealthSystem
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
The study proposal is to deploy a wearable solution that predicts physiological perturbation comparable to invasive devices and to perform continuous remote patient monitoring; this will be connected to a structured, cascading, escalation pathway involving home health nurses, advanced practitioner providers, and heart failure specialists, and has the potential to transform heart failure management in the post-discharge period, where patients are the most vulnerable for readmission. This feasibility study will contribute to the understanding of post-discharge heart failure continuous remote patient monitoring, promote patient self-care, and has the potential of improving patient outcomes.
Detailed Description
Heart failure is a leading cause of hospital readmission. It results in significant mortality, morbidity, and health care utilization. Effective continuous remote patient monitoring (CRPM) can reduce readmissions, but it has only been realized via invasive monitoring. The study will focus on non-invasive heart failure CRPM through a structured cascading and escalating alert system. In this feasibility study, the study team will use a wearable biosensor and collect ambulatory physiological data that are analyzed by machine learning algorithms, potentially identifying physiological perturbation in heart failure patients. Alerts from this algorithm may be cascaded with other patient status data to inform management by the home health team via a structured protocol. The escalation pathway will engage home health, advanced practitioner providers, and heart failure specialists. In the first aim, the study team will perform a soft launch on five patients with an extensive evaluation to assess feasibility for the pilot trial. In aim 2, the study team will implement the feasibility pilot study. In aim 2a, the study team will conduct surveys and semi-structured interviews with both providers and patients. The surveys and interviews will be applied at three time points (initiation, maintenance, and post-study) to evaluate perceptions, acceptance, and experience of this CRPM solution. In aim 2b, the investigators will leverage temporal data mining, feature extraction, and patient clustering methods to identify valid patterns associated with the pathophysiological events of interest, using continuous physiological data, patient reports, and electronic health record data. The study team will also compare outcome and process measures from our pilot study to a retrospective cohort matched for key demographics and disease severity. This feasibility study will provide key learning for a larger efficacy clinical trial to evaluate if this non-invasive telemonitoring solution tied to structured patient management via cascading and escalating alert pathways can improve outcomes and reduce heart failure readmission.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
45 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Pilot
Arm Type
Experimental
Arm Description
45 eligible HF patients
Intervention Type
Other
Intervention Name(s)
Non-invasive continuous remote monitoring with structured escalation pathway
Intervention Description
Continuous patient monitoring through non-invasive biosensors coupled with machine learning algorithms, with a structured escalation and communication pathway for home health providers and HF care team
Intervention Type
Other
Intervention Name(s)
Affective Analysis of Participant Response to Continuous Remote Patient Monitoring
Intervention Description
Surveys and interviews with enrolled participants
Primary Outcome Measure Information:
Title
Attrition rate
Description
Drop out from study
Time Frame
Through study completion, an average 1 year
Title
Enrollment rate
Description
Enrollment rate for entire patient cohort
Time Frame
Through study completion, an average 1 year
Title
Adherence rate
Description
Patient adherence to study protocol requirements
Time Frame
Through study completion, an average 1 year
Title
Time from discharge to first non-adherence event
Description
Days from discharge to first non-adherence event, such as non-compliant use of wearable device
Time Frame
Days from discharge to first non-adherence event up to 30 days post-discharge
Secondary Outcome Measure Information:
Title
Documented Medication adherence counseling
Description
Frequency of medication adherence counseling captured in a note within the electronic health record
Time Frame
30 days from patient discharge date
Title
Documented Dietary counseling
Description
Frequency of dietary counseling captured in a note within the electronic health record
Time Frame
30 days from patient discharge date
Title
Documented Diuretic Escalation
Description
Number of times clinical care team escalated patient standard diuretics dosage
Time Frame
30 days from patient discharge date
Title
30-day readmission rate
Description
30-day readmission rate
Time Frame
30 days from patient discharge date
Title
Average number of clinical alerts from wearable platform
Description
Average number of clinical events from wearable platform within 30 days
Time Frame
30 days from patient discharge date
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient is an inpatient at Evanston Hospital
Patient is followed by the heart failure service team after discharge
Patient has a history of heart failure
Patient received at least one dose of IV diuretic at index hospitalization
Symptoms corresponding to NYHA function class II-IV
Patient has heart failure with reduced left ventricular ejection fraction (LVEF)<40%, or HF with mid-ranged ejection fraction (LVEF 40-50%), or HF with preserved ejection fraction (LVEF≥50%)
Patient is in the top 50% risk of readmission across NorthShore University HealthSystem's CAPE 30-day readmission model
Patient is at least 18 years of age
Patient is fluent in English
Patient agrees to protocol-required procedures
Exclusion Criteria:
Patient has cognitive or physical limitations that, in the investigator's opinion, limit the patient's ability to maintain patch device and phone
Patient has visual impairments
Patient has an allergy to hydrocolloid adhesives
Patient has present skin damage preventing them from wearing a study device
Patient has renal dysfunction requiring dialysis
Patient has CardioMEMS
Pregnancy
Patient receiving hospice care
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Nirav S Shah, MD, MPH
Phone
8476575959
Email
nshah2@northshore.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nirav S Shah
Organizational Affiliation
NorthShore University HealthSystem
Official's Role
Principal Investigator
Facility Information:
Facility Name
NorthShore University HealthSystem Evanston Hospital
City
Evanston
State/Province
Illinois
ZIP/Postal Code
60201
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nirav S Shah, MD, MPH
Phone
847-570-4208
Email
nshah2@northshore.org
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
The Cascade Feasibility Pilot (HF) Phase 3
We'll reach out to this number within 24 hrs